Jacobs was awarded a two-year contract from the Abu Dhabi Department of Energy for project management of a wastewater laboratory that will screen and detect for COVID-19 and other infectious diseases.
Jacobs has successfully applied a machine learning tool – in partnership with the Eugene Water and Electric Board (EWEB) in Oregon – that predicts water quality impacts following forest fires.
Jacobs was awarded an engineering, procurement and construction management contract with Spark Therapeutics, Inc. (Spark) to build its Gene Therapy Innovation Center in the University City area of West Philadelphia. When complete, the multi-story facility will serve as a global center of excellence for gene therapy manufacturing and advance the science of gene therapy.
Jacobs was awarded an extension to its Project Management Resources (PMR) contract with EDF Nuclear Generation, operator of the U.K.'s nuclear power plants. The Jacobs team will continue to support the stations, which account for about 17% of the country's electricity output.
Jacobs was selected to design and deliver the First Plasma Radiological Environmental Monitoring System (REMS), a key safety system for ITER, the world's largest fusion energy experiment.
DALLAS, Nov. 30, 2021 /PRNewswire/ -- The Jacobs Mace joint venture (JV) celebrates Expo 2020 Dubai as visitors discover 192 country pavilions and a host of signature thematic pavilions, thrilling entertainment and state-of-the-art innovative technologies. As the Official Program Delivery
DALLAS, Nov. 25, 2020 /PRNewswire/ -- Jacobs (NYSE:J) has signed a strategic alliance teaming agreement with Biomimicry 3.8 (B3.8), a global consulting and innovation firm specializing in nature-based solutions and nature-inspired designs. Biomimicry is an innovation methodology informed by 3.8
Jacobs was selected to lead two decommissioning projects at the Dounreay nuclear site in Scotland, U.K., which Dounreay Site Restoration Ltd (DSRL) estimates to have a combined value of $15.9 million (£11.2 million).
